Tabla 1: Características generales.

 

Total

Original

p

TAILORx

p

Bajo

Intermedio

Alto

Bajo

Intermedio

Alto

n (%)

n (%)

n (%)

n (%)

n (%)

n (%)

Pacientes

136

72 (52.9)

49 (36.03)

15 (11.03)

 

28 (20.59)

86 (63.24)

22 (16.18)

 

Edad (media)

55.04

55.52

55.26

51.93

0.854

60.68

53.67

53.18

0.013

Histología

Ductal invasor

117 (86.0)

64 (88.9)

38 (77.6)

15 (100)

 

24 (85.7)

73 (84.9)

20 (90.9)

 

Lobulillar invasor

11 (8.1)

4 (5.6)

7 (14.3)

0 (0)

0.115

1 (3.6)

8 (9.3)

2 (9.1)

0.729

Mucinoso

5 (3.7)

2 (2.8)

3 (6.1)

0 (0)

 

1 (3.6)

4 (4.7)

0 (0.0)

 

Mixto

3 (2.2)

2(2.8)

1 (2.0)

0 (0)

 

2 (7.1)

1 (1.2)

0 (0.0)

 

Cirugía

 

 

 

 

 

 

 

 

 

MRM

60 (45.5)

35 (51.5)

19 (38.8)

6 (40.0)

 

12 (46.2)

38 (45.2)

10 (45.5)

 

MS

7 (5.3)

2 (2.9)

5 (10.2)

0 (0.0)

0.778

1 (3.8)

6 (7.1)

0 (0.0)

0.883

MCCAP

13 (9.8)

6 (8.8)

3 (6.1)

4 (26.7)

 

2 (7.7)

7 (8.3)

4 (18.2)

 

CC

52 (39.4)

25 (36.8)

22 (44.9)

5 (33.3)

 

11 (42.3)

33 (39.3)

8 (36.4)

 

Tamaño tumoral

T1mi

1 (0.7)

1 (1.4)

0 (0.0)

0 (0.0)

 

1 (3.6)

0 (0.0)

0 (0.0)

 

T1a

4 (2.9)

3 (4.2)

1 (2.0)

0 (0.0)

0.858

0 (0.0)

4 (4.7)

0 (0.0)

0.815

T1b

31 (22.8)

16 (22.2)

10 (20.4)

5 (33.3)

 

6 (21.4)

19 (22.1)

6 (27.3)

 

T1c

74 (54.4)

39 (54.2)

29 (59.2)

6 (40.0)

 

16 (57.1)

48 (55.8)

10 (45.5)

 

T2

26 (19.1)

13 (18.1)

9 (18.4)

4 (26.7)

 

5 (17.9)

15 (17.4)

6 (27.3)

 

Ganglios

pN0

111 (81.6)

64 (88.9)

35 (71.4)

12 (80.0)

0.052

25 (89.3)

70 (81.4)

16 (72.7)

0.443

pN1

25 (18.4)

8 (11.1)

14 (28.6)

3 (20.0)

 

3 (10.7)

16 (18.6)

6 (27.3)

 

Etapa clínica

IA

93 (68.4)

56 (77.8)

28 (57.1)

9 (60.0)

0.139

21 (75.0)

60 (69.8)

12 (54.5)

0.202

IB

5 (3.7)

1 (1.4)

4 (8.2)

0 (0.0)

 

0 (0.0)

5 (5.8)

0 (0.0)

 

IIA

36 (26.5)

14 (19.4)

16 (32.7)

6 (40.0)

 

7 (25.0)

19 (22.1)

10 (45.5)

 

IIB

2 (1.5)

1 (1.4)

1 (2.0)

0 (0.0)

 

0 (0.0)

2 (2.3)

0 (0.0)

 

RE

Positivo

136 (100.0)

72 (100.0)

49 (100.0)

15 (100.0)

28 (100.0)

86 (100.0)

22 (100.0)

Negativo

0 (0.0)

0 (0.0)

0 (0.0)

0 (0.0)

 

0 (0.0)

0 (0.0)

0 (0.0)

 

RP

Positivo

120 (88.2)

70 (97.2)

42 (85.7)

8 (53.3)

27 (96.4)

81 (94.2)

12 (54.5)

Negativo

16 (11.8)

2 (2.8)

7 (14.3)

7 (46.7)

 

1 (3.6)

5 (5.8)

10 (45.5)

 

RE % media

76.02

75.94

75.79

76.02

0.483

76.85

75.94

76.02

0.650

RP % media

57.8

59.3

58.56

59.71

0.339

59.0

59.34

59.71

0.371

RE > 50%

105 (82.0)

60 (87.0)

36 (81.8)

9 (60.0)

0.022

27 (100.0)

65 (80.2)

13 (65.0)

0.004

RP > 50%

83 (63.4)

52 (75.4)

26 (55.3)

5 (33.3)

< 0.001

24 (88.9)

51 (61.4)

8 (38.1)

< 0.001

Her2 (-)

135 (99.3)

72 (100.0)

49 (100.0)

14 (93.3)

 

28 (100.0)

86 (100.0)

21 (95.5)

 

Grado Dif.

G1

39 (28.7)

27 (37.5)

11 (22.4)

1 (6.7)

0.010

9 (32.1)

29 (33.7)

1 (4.5)

0.008

G2

83 (61.0)

41 (56.9)

31 (63.3)

11 (73.3)

 

17 (60.7)

50 (58.1)

16 (72.7)

 

G3

14 (10.3)

4 (5.6)

7 (14.3)

3 (20.0)

 

2 (7.1)

7 (8.1)

5 (22.7)

 

Ki67 media

15.90

12.86

15.04

33.35

0.079

13.34

12.56

32.24

0.088

Ki67 > 14%

55 (40.4)

27 (37.5)

16 (32.7)

12 (80.0)

0.004

10 (35.7)

28 (32.6)

17 (77.3)

0.001

ILV+

41(30.1)

18 (25.0)

14 (28.6)

9 (60.0)

0.026

5 (17.9)

25 (29.1)

11 (50.0)

0.046

IPN+

29 (21.3)

15 (20.8)

9 (18.4)

5 (33.3)

0.460

22 (78.6)

69 (80.2)

16 (72.7)

0.745

MRM = mastecomía radica modificada, MS = mastectomía simple,

MCCAP = mastectomía conservadora de complejo areola pezón, CC = cirugía conservadora,
RE = receptores de estrógenos, RP = receptores de progesterona,

ILV = invasión linfovascular, IPN = invasión perineural.